• Something wrong with this record ?

Upgrade Rate and Predictive Factors Associated With Breast Papillary Lesions on Core Biopsy: A Canadian Experience

T. Salisbury, A. Gurung, S. Koonmee, L. Ali, O. Ondic, R. Bhan, K. Pivovarcikova, O. Hes, R. Alaghehbandan

. 2023 ; 31 (7) : 1206-1216. [pub] 20221127

Language English Country United States

Document type Journal Article

Background: Papillary lesions of the breast are a heterogeneous group, encompassing a wide range of lesions. The histologic distinction between papillary breast lesions remains challenging, especially on core biopsy specimens. Aim: This study aimed to determine the rate of upgrade to atypia or malignancy of biopsy-proven papillary lesions on surgical follow-up and to assess for factors associated with an upgrade in Greater Vancouver, BC, Canada. Materials and Methods: This is a retrospective population-based study of all breast papillary lesions diagnosed on core biopsy between 2017 and 2019 in the Fraser Health Authority in Greater Vancouver, Canada. Patients were retrieved from the laboratory information system. Patient demographics, histopathologic, and radiologic findings were analyzed. Results: A total of 269 specimens from 269 patients (mean 61.1 years), including 265 female and 4 male patients, were included in the study. Of the 269 specimens, 129 (48%) were intraductal papillomas and 140 (52%) were atypical papillary lesions. The overall upgrade rate among papillomas was 11.6% (15 of 129) on final excision. The mean age of patients diagnosed with papilloma on core biopsy was significantly younger than those with atypical papillary lesions (55.6 vs 66.1 years, P < .0001). Lesion size in patients with papillomas on core biopsy was significantly smaller than those with atypical papillary lesions (11.1 vs 15.1 mm, P = .001). The upgrade rates in patients <55 and ≥55 years were 4.9% and 13.2%. Size (P = .004) and atypia on core biopsy (P = .009) were significantly associated with upgrade. Older age (>55 years) (OR = 5.3, 95% CI: 1.04-27.08) was an independent predictor of upgrade among papillomas. Size, location, and Breast Imaging-Reporting and Data System (BI-RADS) radiologic categories in our study were not associated with predicting the upgrade of papillomas. Conclusion: Our data suggest that the risk of upgrade to atypia or malignancy is sufficient to warrant the excision of benign papillomas of any size in patients aged ≥55 years. In patients younger than 55 years, observation with close clinical and radiological follow-up without surgery may be sufficient. Our findings also support surgical excision of papillomas diagnosed on core biopsy when associated with atypia.

References provided by Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc24001200
003      
CZ-PrNML
005      
20240213094432.0
007      
ta
008      
240109s2023 xxu f 000 0|eng||
009      
AR
024    7_
$a 10.1177/10668969221137515 $2 doi
035    __
$a (PubMed)36437635
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a xxu
100    1_
$a Salisbury, Taylor $u Department of Pathology, Faculty of Medicine, The University of British Columbia, Vancouver, BC, Canada
245    10
$a Upgrade Rate and Predictive Factors Associated With Breast Papillary Lesions on Core Biopsy: A Canadian Experience / $c T. Salisbury, A. Gurung, S. Koonmee, L. Ali, O. Ondic, R. Bhan, K. Pivovarcikova, O. Hes, R. Alaghehbandan
520    9_
$a Background: Papillary lesions of the breast are a heterogeneous group, encompassing a wide range of lesions. The histologic distinction between papillary breast lesions remains challenging, especially on core biopsy specimens. Aim: This study aimed to determine the rate of upgrade to atypia or malignancy of biopsy-proven papillary lesions on surgical follow-up and to assess for factors associated with an upgrade in Greater Vancouver, BC, Canada. Materials and Methods: This is a retrospective population-based study of all breast papillary lesions diagnosed on core biopsy between 2017 and 2019 in the Fraser Health Authority in Greater Vancouver, Canada. Patients were retrieved from the laboratory information system. Patient demographics, histopathologic, and radiologic findings were analyzed. Results: A total of 269 specimens from 269 patients (mean 61.1 years), including 265 female and 4 male patients, were included in the study. Of the 269 specimens, 129 (48%) were intraductal papillomas and 140 (52%) were atypical papillary lesions. The overall upgrade rate among papillomas was 11.6% (15 of 129) on final excision. The mean age of patients diagnosed with papilloma on core biopsy was significantly younger than those with atypical papillary lesions (55.6 vs 66.1 years, P < .0001). Lesion size in patients with papillomas on core biopsy was significantly smaller than those with atypical papillary lesions (11.1 vs 15.1 mm, P = .001). The upgrade rates in patients <55 and ≥55 years were 4.9% and 13.2%. Size (P = .004) and atypia on core biopsy (P = .009) were significantly associated with upgrade. Older age (>55 years) (OR = 5.3, 95% CI: 1.04-27.08) was an independent predictor of upgrade among papillomas. Size, location, and Breast Imaging-Reporting and Data System (BI-RADS) radiologic categories in our study were not associated with predicting the upgrade of papillomas. Conclusion: Our data suggest that the risk of upgrade to atypia or malignancy is sufficient to warrant the excision of benign papillomas of any size in patients aged ≥55 years. In patients younger than 55 years, observation with close clinical and radiological follow-up without surgery may be sufficient. Our findings also support surgical excision of papillomas diagnosed on core biopsy when associated with atypia.
650    _2
$a ženské pohlaví $7 D005260
650    _2
$a lidé $7 D006801
650    _2
$a mužské pohlaví $7 D008297
650    _2
$a senioři $7 D000368
650    _2
$a retrospektivní studie $7 D012189
650    _2
$a biopsie dutou jehlou $7 D062005
650    12
$a papilom $x patologie $7 D010212
650    12
$a nádory prsu $x diagnóza $7 D001943
651    _2
$a Kanada $7 D002170
655    _2
$a časopisecké články $7 D016428
700    1_
$a Gurung, Ananta $u Department of Pathology, Faculty of Medicine, The University of British Columbia, Vancouver, BC, Canada
700    1_
$a Koonmee, Supinda $u Department of Pathology, Faculty of Medicine, Khon Kaen University, Khon Kaen, Thailand
700    1_
$a Ali, Leila $u Department of Pathology, Carol Davila University of Medicine and Pharmacy, Bucharest, Romania
700    1_
$a Ondic, Ondrej $u Department of Pathology, Faculty of Medicine, Charles University, Plzen, Czech Republic
700    1_
$a Bhan, Rohan $u Department of Medicine, Saba University School of Medicine, The Bottom, Saba, Dutch Caribbean
700    1_
$a Pivovarcikova, Kristyna $u Department of Pathology, Faculty of Medicine, Charles University, Plzen, Czech Republic
700    1_
$a Hes, Ondrej $u Department of Pathology, Faculty of Medicine, Charles University, Plzen, Czech Republic
700    1_
$a Alaghehbandan, Reza $u Department of Anatomic Pathology, Robert J. Tomsich Pathology and Laboratory Medicine Institute, Cleveland Clinic, Cleveland, OH, USA $1 https://orcid.org/0000000267085032
773    0_
$w MED00002376 $t International journal of surgical pathology $x 1940-2465 $g Roč. 31, č. 7 (2023), s. 1206-1216
856    41
$u https://pubmed.ncbi.nlm.nih.gov/36437635 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y - $z 0
990    __
$a 20240109 $b ABA008
991    __
$a 20240213094429 $b ABA008
999    __
$a ok $b bmc $g 2049672 $s 1210894
BAS    __
$a 3
BAS    __
$a PreBMC-MEDLINE
BMC    __
$a 2023 $b 31 $c 7 $d 1206-1216 $e 20221127 $i 1940-2465 $m International journal of surgical pathology $n Int. j. surg. pathol. $x MED00002376
LZP    __
$a Pubmed-20240109

Find record

Citation metrics

Loading data ...

Archiving options

Loading data ...